EISENBERG GLENN A — SEC Form 4 filings
SEC reporting owner CIK 1222831. 22 Form 4 filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2024-02-06 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 3 filings — 61,215 shares, $13,627,342 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: sale of 18,379 shares @ $215.37 ($3,958,214) in LABCORP HOLDINGS INC., filed 2024-02-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | Executive Vice President | 12 | — | 8 legs · 61,215 sh · $13,627,342 | 37 |
| Solventum Corp (SOLV) | Director | 6 | — | — | 10 |
| MIDDLEBY Corp (MIDD) | Director | 2 | — | — | 2 |
| Lumexa Imaging Holdings, Inc. (LMRI) | Director | 1 | — | — | 1 |
| MiniMed Group, Inc. (MMED) | Director | 1 | — | — | 1 |
Form 4 filings — EISENBERG GLENN A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | MIDDLEBY Corp (MIDD) | Conversion (C): 349 | EDGAR |
| 2026-06-12 | 4 | Lumexa Imaging Holdings, Inc. (LMRI) | Grant/award (A): 19,358 @ $0 | EDGAR |
| 2026-05-18 | 4 | Solventum Corp (SOLV) | Grant/award (A): 3,300 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Solventum Corp (SOLV) | Option exercise (M): 3,403 @ $0 · Option exercise (M): 3,403 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Solventum Corp (SOLV) | Option exercise (M): 1,980 @ $0 · Option exercise (M): 1,980 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | MiniMed Group, Inc. (MMED) | Grant/award (A): 13,889 @ $0 | EDGAR |
| 2026-03-06 | 4 | MIDDLEBY Corp (MIDD) | Grant/award (A): 1,161 | EDGAR |
| 2025-05-15 | 4 | Solventum Corp (SOLV) | Option exercise (M): 3,564 @ $0 · Option exercise (M): 3,564 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Solventum Corp (SOLV) | Grant/award (A): 3,403 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 8,305 @ $0 · Tax withholding (F): 3,630 @ $231.67 | EDGAR |
| 2025-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 807 · Tax withholding (F): 213 @ $245.14 · Option exercise (M): 807 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 966 · Tax withholding (F): 255 @ $247.74 · Option exercise (M): 885 · Tax withholding (F): 234 @ $246.27 · Option exercise (M): 966 (derivative) @ $0 · Option exercise (M): 885 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 8,923 @ $209.25 · Option exercise (M): 2,788 @ $221.67 · Sale (S): 11,711 @ $240.43 · Option exercise (M): 8,923 (derivative) @ $0 · Option exercise (M): 2,788 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 2,979 @ $222.65 · Sale (S): 2,950 @ $223.62 · Sale (S): 9,071 @ $224.55 | EDGAR |
| 2024-05-15 | 4 | Solventum Corp (SOLV) | Grant/award (A): 3,564 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 10,229 · Tax withholding (F): 4,496 @ $201.37 · Option exercise (M): 10,229 (derivative) | EDGAR |
| 2024-04-17 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 10,229 · Tax withholding (F): 4,496 @ $203.32 · Option exercise (M): 10,229 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 20,033 · Tax withholding (F): 8,805 @ $216.57 · Option exercise (M): 20,033 (derivative) | EDGAR |
| 2024-02-22 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 14,054 @ $163.63 · Sale (S): 18,379 @ $215.37 · Sale (S): 7,907 @ $215.68 · Sale (S): 6,665 @ $217.52 · Sale (S): 1,553 @ $217.98 · Option exercise (M): 14,054 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 807 · Tax withholding (F): 215 @ $227.45 · Option exercise (M): 807 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 885 · Tax withholding (F): 236 @ $223.71 · Grant/award (A): 2,900 (derivative) @ $0 · Grant/award (A): 9,000 (derivative) @ $0 · Option exercise (M): 885 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 856 · Tax withholding (F): 228 @ $221.54 · Option exercise (M): 856 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1222831 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →